Oral Tranexamic Acid

Tranexamic acid is a clotting drug that turned out, unexpectedly, to fade melasma. The discovery was accidental — patients taking it for bleeding noticed their pigment fading.

The mechanism connects two things that seem unrelated:

It blocks plasmin. When UV light hits your skin, surface skin cells release a messenger molecule called plasmin. Plasmin travels to nearby melanocytes (pigment cells) and tells them to ramp up melanin production. Tranexamic acid blocks plasmin — so the "make more pigment" order never gets delivered.

This is a genuinely different point of attack. Hydroquinone blocks the enzyme that makes pigment. Tranexamic acid blocks the signal telling the cell to make it at all — it intervenes one step earlier.

It reduces the blood vessels in melasma patches. This is the part that makes it special. Melasma isn't purely a pigment problem — melasma skin has increased numbers of small blood vessels, and those vessels release their own signals telling melanocytes to keep producing pigment. Most treatments ignore this entirely.

Tranexamic acid targets that vascular component. It's a large part of why it works on melasma that has stubbornly resisted everything else, and why it's become a go-to for exactly those cases.

It calms inflammation, and inflammation is itself a pigment trigger.

The practical upshot: tranexamic acid attacks melasma from angles that hydroquinone and retinoids don't — so it often works when they haven't, and it combines well with them rather than duplicating them.

Typical dose for melasma: 250 mg twice daily. Some dermatologists use 325 mg twice daily.

Note how low this is. The dose for heavy menstrual bleeding is roughly 1,300 mg three times daily — more than five times higher. This matters, because the clotting risks people worry about come from studies at those much higher doses. The melasma dose is a small fraction of it.

Course length: typically 3–6 months, then reassess. Some people do intermittent courses for flares.

Timeline: improvement usually begins at 8–12 weeks. Not fast.

Before starting, expect a screening conversation about:

• Any personal or family history of blood clots (DVT, pulmonary embolism)
• Whether you smoke
• Whether you take estrogen-containing contraception or HRT
• Any clotting disorder
• Recent or upcoming surgery, or prolonged immobility

This screening is the whole safety story of this drug. Done properly, serious complications are rare.

Sunscreen is non-negotiable. UV is the primary driver of melasma, and it triggers the plasmin signal this drug blocks. Taking tranexamic acid without daily sunscreen is working directly against yourself.

It combines well with hydroquinone, retinoids, azelaic acid, and niacinamide — because it works on entirely different steps of pigment production.

Melasma is chronic. Expect it to return without maintenance and sun protection.

Usually well tolerated at the low doses used for melasma.

Nausea or stomach upset. The most common. Taking it with food helps.

Bloating.

Diarrhea.

Headache.

Lighter periods. Expected — the drug reduces bleeding, which is its original purpose. Many people consider this a bonus.

Muscle aches.

Fatigue.

Most side effects are mild and settle. Serious side effects are rare at these doses in properly screened patients.

Blood clots (DVT and pulmonary embolism). This is the risk that defines the drug, and the reason for the careful screening.

Tranexamic acid works by reducing the breakdown of clots. In someone already prone to clotting, that's a real hazard.

In practice, at the low doses used for melasma and in patients screened for clot risk, the incidence is very low — and studies have not shown a meaningful increase in clot risk in appropriately selected patients. The safety of this drug lies almost entirely in who you give it to.

Seek urgent care for:

• Swelling, pain, redness, or warmth in one leg (possible DVT)
• Chest pain, shortness of breath, or coughing blood (possible pulmonary embolism)
• Sudden severe headache, vision changes, weakness on one side, or difficulty speaking (possible stroke)

Visual disturbance. Rare. Report any change in vision or color vision — the drug should be stopped.

Seizures. Reported at very high intravenous doses. Not a realistic concern at oral melasma doses.

Pregnancy: avoid for melasma. Tranexamic acid does cross the placenta, and pregnancy itself already raises clotting risk substantially. Combining the two for a cosmetic indication isn't a reasonable trade.

This is worth stating plainly, because pregnancy is one of the most common triggers for melasma — so exactly the people who develop it are often the ones who can't take this.

Safe pregnancy alternatives: azelaic acid (the standard choice), niacinamide, vitamin C, and above all rigorous sun protection. Pregnancy-triggered melasma often fades on its own after delivery.

Breastfeeding: small amounts pass into breast milk. Generally avoided for a cosmetic indication; discuss with your doctor.

Contraception matters here. Estrogen-containing birth control pills also raise clotting risk. Combining them with tranexamic acid raises it further, and many dermatologists will avoid the combination or recommend switching to a non-estrogen method. Be upfront about what you're taking.

Do not take if you have:

• A history of blood clots — DVT, pulmonary embolism, stroke, or heart attack
• An active clot or clotting disorder (such as Factor V Leiden)
• A strong family history of clotting disorders
• Acquired defective color vision
• Subarachnoid hemorrhage
• Severe kidney impairment (dose adjustment needed)
• A known allergy to tranexamic acid

Serious caution / usually avoided:

• Smokers, particularly heavy smokers — smoking raises clot risk independently
• Estrogen-containing contraception or HRT — also raises clot risk. Many dermatologists avoid this combination or ask you to switch to a progestin-only method.
• Pregnancy and breastfeeding
• Recent surgery or prolonged immobility
• Long-haul flights — worth mentioning if travel is coming up

Tell your doctor about: anticoagulants, clotting factor products, and hormonal medications.

The screening is the safety net. Be complete and honest about your history — this is a drug where the risk is almost entirely determined by whether it should have been prescribed to you in the first place.

Isn't this a blood clotting drug? Is it safe?
It is — it's approved for heavy menstrual bleeding. The safety of using it for melasma comes down to two things:

1. The dose is much lower. 250 mg twice daily for melasma, versus around 1,300 mg three times daily for bleeding. Roughly a fifth of the dose.
2. Patients are screened. Anyone with a clot history, clotting disorder, or major risk factors shouldn't take it.

In properly screened patients at these doses, studies have not shown a meaningful increase in clot risk. But the screening is not a formality — it's the entire reason it's safe.

Why does it work when nothing else has?
Because it attacks melasma from an angle other treatments don't. It blocks the signal (plasmin) that tells pigment cells to overproduce — one step upstream of where hydroquinone acts. And it reduces the extra blood vessels in melasma patches, which release their own pigment-promoting signals. Most brighteners ignore that vascular component entirely. That's why oral TXA often succeeds where hydroquinone and retinoids have plateaued.

How long until it works?
8–12 weeks. Courses typically run 3–6 months. Be patient.

Can I take it with birth control?
Estrogen-containing pills raise clot risk on their own, and combining them with tranexamic acid raises it further. Many dermatologists avoid this combination or suggest switching to a progestin-only method. Tell your doctor exactly what you're taking.

Can I take it if I smoke?
Smoking independently raises clot risk, and most dermatologists are cautious or unwilling here. This is a genuinely good reason to stop smoking — but it also means the drug may not be an option for you right now.

Will it make my periods lighter?
Yes, likely — that's its original purpose. Many people find this a welcome side effect.

Is topical tranexamic acid as good?
Topical TXA is safer and needs no screening, but it is considerably less effective than the oral form. It's a reasonable maintenance option, especially during breaks from oral treatment or for people who can't take the pill. For stubborn melasma, oral works better.

Will my melasma come back?
Probably, without sun protection. Melasma is chronic — the pigment cells stay primed. Tranexamic acid clears it; sunscreen and maintenance keep it clear. The sunscreen isn't optional here — UV triggers the exact plasmin signal this drug blocks.

Can I combine it with hydroquinone or Tri-Luma?
Yes, and it's common. They work on different steps of pigment production, so the effects add up rather than overlap. This combination is often used for melasma that hasn't responded to topicals alone.